Clinical Trial Update: Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers [NA]

View source ↗

Summary

A completed double-blind study evaluating the efficacy of CannaXR in reducing UVA premutagenic and photoaging markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging

Drugs mentioned

• CannaXR

Snippet

Sponsor: MINO Labs, LLC | Conditions: Photoaging | NA | Status: COMPLETED